Production & Manufacturing

Examination of the pharmaceutical industry's transition toward biodegradable polymers and eco-friendly excipients to reduce environmental impact while maintaining high therapeutic standards.

Analysis of the evolving landscape of parenteral delivery, focusing on the stability of high-concentration biologics and the integration of patient-centric delivery devices.

Exploration of the chemical, physical, and environmental factors that compromise the integrity of modern therapeutics, and the advanced testing protocols used to ensure safety.

Detailed review of how lipidic excipients and nano-emulsified systems are utilized to enhance the absorption and bioavailability of hydrophobic pharmaceutical compounds.

Analysis of the chemical and physical methodologies employed to overcome solubility and permeability barriers, ensuring active pharmaceutical ingredients reach systemic circulation effectively.

Exploration of how sophisticated delivery mechanisms enhance medical efficacy, reduce side effects, and enable personalized treatment across oncology, neurology, and chronic disease management.

Halo Pharma becomes dedicated North American drug product CDMO after emerging as a standalone contract development and manufacturing organization focused exclusively on drug product services in North America. The transition follows SK Capital Partners’ decision to divest the active...